EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 121 filers reported holding EPIZYME INC in Q1 2022. The put-call ratio across all filers is 4.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,229,000 | +30.6% | 836,955 | +2.3% | 0.00% | – |
| Q1 2022 | $941,000 | -52.2% | 818,391 | +3.8% | 0.00% | – |
| Q4 2021 | $1,970,000 | -85.8% | 788,360 | -70.9% | 0.00% | -100.0% |
| Q3 2021 | $13,867,000 | -17.5% | 2,708,473 | +33.8% | 0.00% | 0.0% |
| Q2 2021 | $16,817,000 | +2.7% | 2,023,752 | +7.7% | 0.00% | 0.0% |
| Q1 2021 | $16,367,000 | -19.4% | 1,879,041 | +0.5% | 0.00% | -33.3% |
| Q4 2020 | $20,300,000 | +17.4% | 1,869,246 | +29.0% | 0.00% | 0.0% |
| Q3 2020 | $17,291,000 | +56.8% | 1,449,327 | +111.1% | 0.00% | +50.0% |
| Q2 2020 | $11,026,000 | +675.4% | 686,569 | +648.8% | 0.00% | – |
| Q1 2020 | $1,422,000 | -85.0% | 91,695 | -76.3% | 0.00% | -100.0% |
| Q4 2019 | $9,511,000 | +219.5% | 386,637 | +33.9% | 0.00% | +100.0% |
| Q3 2019 | $2,977,000 | -22.7% | 288,702 | -5.9% | 0.00% | 0.0% |
| Q2 2019 | $3,852,000 | -9.3% | 306,908 | -10.5% | 0.00% | 0.0% |
| Q1 2019 | $4,247,000 | +44.8% | 342,862 | -28.0% | 0.00% | 0.0% |
| Q4 2018 | $2,932,000 | -47.4% | 476,027 | -9.4% | 0.00% | 0.0% |
| Q3 2018 | $5,572,000 | -30.4% | 525,694 | -11.0% | 0.00% | -50.0% |
| Q2 2018 | $8,003,000 | +159.6% | 590,684 | +240.0% | 0.00% | +100.0% |
| Q1 2018 | $3,083,000 | +122.6% | 173,745 | +57.4% | 0.00% | – |
| Q4 2017 | $1,385,000 | -24.9% | 110,366 | +14.0% | 0.00% | -100.0% |
| Q3 2017 | $1,845,000 | +141.8% | 96,845 | +91.7% | 0.00% | – |
| Q2 2017 | $763,000 | -73.0% | 50,512 | -69.4% | 0.00% | – |
| Q1 2017 | $2,830,000 | -7.8% | 165,026 | -35.0% | 0.00% | -100.0% |
| Q4 2016 | $3,068,000 | +21.8% | 253,742 | -0.9% | 0.00% | 0.0% |
| Q3 2016 | $2,519,000 | -9.0% | 256,067 | -5.2% | 0.00% | 0.0% |
| Q2 2016 | $2,767,000 | -20.4% | 270,216 | -5.7% | 0.00% | 0.0% |
| Q1 2016 | $3,474,000 | -25.9% | 286,683 | -2.1% | 0.00% | -50.0% |
| Q4 2015 | $4,690,000 | +17.7% | 292,735 | -5.5% | 0.00% | +100.0% |
| Q3 2015 | $3,984,000 | +818.0% | 309,790 | +1610.9% | 0.00% | – |
| Q2 2015 | $434,000 | +28.4% | 18,107 | +0.6% | 0.00% | – |
| Q1 2015 | $338,000 | -66.8% | 18,001 | -66.6% | 0.00% | – |
| Q4 2014 | $1,018,000 | -35.8% | 53,947 | -7.8% | 0.00% | -100.0% |
| Q3 2014 | $1,586,000 | +186.3% | 58,503 | +228.8% | 0.00% | – |
| Q2 2014 | $554,000 | +56.1% | 17,792 | +14.1% | 0.00% | – |
| Q1 2014 | $355,000 | +1.7% | 15,588 | -7.2% | 0.00% | – |
| Q4 2013 | $349,000 | -27.0% | 16,802 | +40.6% | 0.00% | – |
| Q3 2013 | $478,000 | -77.1% | 11,948 | -83.9% | 0.00% | -100.0% |
| Q2 2013 | $2,087,000 | – | 74,205 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
| Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
| Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
| MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
| Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
| Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
| Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
| Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
| Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
| Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |